Masumoto, N., Otsuki, H., Iwakawa, S., Inada, S., & Koga, M. (2016). Usefulness of glycated albumin in decisions regarding the discontinuation of a diabetes drug and factors associated with poor glycemic control following discontinuation in patients with type 2 diabetes mellitus. Diabetol Int.
Chicago Style CitationMasumoto, Norio, Hiroaki Otsuki, Seigo Iwakawa, Shinya Inada, i Masafumi Koga. "Usefulness of Glycated Albumin in Decisions Regarding the Discontinuation of a Diabetes Drug and Factors Associated With Poor Glycemic Control Following Discontinuation in Patients With Type 2 Diabetes Mellitus." Diabetol Int 2016.
Cita MLAMasumoto, Norio, et al. "Usefulness of Glycated Albumin in Decisions Regarding the Discontinuation of a Diabetes Drug and Factors Associated With Poor Glycemic Control Following Discontinuation in Patients With Type 2 Diabetes Mellitus." Diabetol Int 2016.